Targeted Drug Delivery to Flow-Obstructed Blood Vessels Using Mechanically Activated Nanotherapeutics
Authors:
- 1 January 2015
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 72 (1) , 119-22
Abstract
Review from JAMA Neurology — Targeted Drug Delivery to Flow-Obstructed Blood Vessels Using Mechanically Activated NanotherapeuticsKeywords
This publication has 9 references indexed in Scilit:
- Stent Retrievers in Acute Ischemic Stroke: Complications and Failures during the Perioperative PeriodAmerican Journal of Neuroradiology, 2013
- The Shear Stress of Busting Blood ClotsNew England Journal of Medicine, 2012
- Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trialThe Lancet, 2012
- Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood VesselsScience, 2012
- Shear-stress sensitive lenticular vesicles for targeted drug deliveryNature Nanotechnology, 2012
- Abciximab as Adjunctive Therapy to Reperfusion in Acute ST-Segment Elevation Myocardial Infarction: A Meta-analysis of Randomized TrialsACC Current Journal Review, 2005
- RETRACTED ARTICLE: Tissue plasminogen activator neurovascular toxicity is controlled by activated protein CNature Medicine, 2004
- Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activatorNeurology, 2002
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992